Palliative chemotherapy with or without cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck: Indian tertiary care retrospective analysis

Ankur Bahl; Komal Bhatia; Pragati Choudhary; Suhas Singhla; Gunjan Shrivastava; Jaspriya Bal; Anil K. Anand; Harit Chaturvedi; Bharat Dua

doi:10.1002/hed.26070

Palliative chemotherapy with or without cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck: Indian tertiary care retrospective analysis

Head & Neck ◽

10.1002/hed.26070 ◽

2020 ◽

Vol 42 (5) ◽

pp. 955-962 ◽

Cited By ~ 2

Author(s):

Ankur Bahl ◽

Komal Bhatia ◽

Pragati Choudhary ◽

Suhas Singhla ◽

Gunjan Shrivastava ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Retrospective Analysis ◽

Squamous Cell ◽

Palliative Chemotherapy ◽

Tertiary Care ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Palliative chemotherapy (CT) with or without cetuximab (CTX) in recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): An Indian retrospective analysis

Annals of Oncology ◽

10.1093/annonc/mdy438.031 ◽

2018 ◽

Vol 29 ◽

pp. ix103

Author(s):

A. Bahl ◽

P. Choudhary ◽

K. Bhatia ◽

S. Singhla ◽

G. Shrivastava ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Retrospective Analysis ◽

Squamous Cell ◽

Palliative Chemotherapy ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial

Annals of Oncology ◽

10.1093/annonc/mdt574 ◽

2014 ◽

Vol 25 (4) ◽

pp. 801-807 ◽

Cited By ~ 134

Author(s):

J.B. Vermorken ◽

A. Psyrri ◽

R. Mesía ◽

F. Peyrade ◽

F. Beier ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Retrospective Analysis ◽

Squamous Cell ◽

Phase Iii ◽

Hpv Status ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

A Retrospective Analysis of the Outcome of Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Refractory to a Platinum-based Chemotherapy

Clinical Oncology ◽

10.1016/j.clon.2005.02.014 ◽

2005 ◽

Vol 17 (6) ◽

pp. 418-424 ◽

Cited By ~ 103

Author(s):

X. León ◽

R. Hitt ◽

M. Constenla ◽

A. Rocca ◽

R. Stupp ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Retrospective Analysis ◽

Squamous Cell ◽

Platinum Based Chemotherapy ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

275P Weekly paclitaxel, carboplatin and cetuximab (PCC) combination followed by nivolumab in platinum-sensitive recurrent and /or metastatic squamous cell carcinoma of head and neck: A double institution retrospective analysis from India

Annals of Oncology ◽

10.1016/j.annonc.2020.10.269 ◽

2020 ◽

Vol 31 ◽

pp. S1350

Author(s):

V. Agarwala ◽

M.V. Chandrakanth ◽

P.K. Mondal ◽

R. Chanana

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Retrospective Analysis ◽

Squamous Cell ◽

Weekly Paclitaxel ◽

Platinum Sensitive ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

319P The role of cetuximab maintenance after chemotherapy in patients with recurrent/metastatic squamous cell carcinoma of head and neck (R/M SCCHN): A retrospective analysis

Annals of Oncology ◽

10.1093/annonc/mdv527.06 ◽

2015 ◽

Vol 26 ◽

pp. ix93

Author(s):

T. Wakasugi ◽

T. Enokida ◽

A. Nakanome ◽

T. Yamazaki ◽

S. Okano ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Retrospective Analysis ◽

Squamous Cell ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Palliative Chemotherapy in Recurrent or Metastatic Squamous cell carcinoma of the head and neck, NEMROCK experience

Research in Oncology ◽

10.21608/resoncol.2013.876 ◽

2013 ◽

Vol 9 (Issue 3-4) ◽

pp. 69-73

Author(s):

Hisham Atef ◽

Amr Sakr ◽

Tamer El-Nahas

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Palliative Chemotherapy ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14264023.15777137 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Clinical Activity ◽

Molecular Response ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): a trial of the Eastern Cooperative Oncology Group.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954085.793459863 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Proteasome Inhibitor ◽

Eastern Cooperative Oncology Group ◽

Oncology Group ◽

Metastatic Squamous Cell Carcinoma ◽

Locally Recurrent

Download Full-text

Faculty Opinions recommendation of Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954885.793461177 ◽

2012 ◽

Author(s):

Sandra Nuyts

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Preclinical Data ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Comparison of second-line treatments of recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734912521.793555705 ◽

2019 ◽

Author(s):

Ricardo Hitt

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Second Line ◽

Metastatic Squamous Cell Carcinoma

Download Full-text